| Literature DB >> 35456116 |
Hector A Rojas1, Brad J White1, David E Amrine1, Robert L Larson1.
Abstract
Bovine respiratory disease (BRD) is the leading cause of morbidity in feedlot cattle. The ability to accurately identify the expected BRD risk of cattle would allow managers to detect high-risk animals more frequently. Five classification models were built and evaluated towards predicting the expected BRD risk (high/low) of feedlot cattle within the first 45 days on feed (DOF) and incorporate an economic analysis to determine the potential health cost advantage when using a predictive model compared with standard methods. Retrospective data from 10 U.S. feedlots containing 1733 cohorts representing 188,188 cattle with known health outcomes were classified into high- (≥15% BRD morbidity) or low- (<15%) BRD risk in the first 45 DOF. Area under the curve was calculated from the test dataset for each model and ranged from 0.682 to 0.789. The economic performance for each model was dependent on the true proportion of high-risk cohorts in the population. The decision tree model displayed a greater potential economic advantage compared with standard procedures when the proportion of high-risk cohorts was ≤45%. Results illustrate that predictive models may be useful at delineating cattle as high or low risk for disease and may provide economic value relative to standard methods.Entities:
Keywords: bovine respiratory disease; economic analysis; predictive modeling
Year: 2022 PMID: 35456116 PMCID: PMC9029152 DOI: 10.3390/pathogens11040442
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Final diagnostic performance estimates utilizing the test dataset for BRD morbidity risk during the first 45 days on feed to classify cohorts as high or low risk for BRD development within the first 45 days post arrival using a 15% cutoff at the optimum cutoff where 10.85% of the cohorts had >15% BRD morbidity.
| Performance Metric | Logistic | Decision Tree | Random | Naïve | Linear |
|---|---|---|---|---|---|
| AUC 1 | 0.785 | 0.682 | 0.789 | 0.743 | 0.760 |
| True Positives | 40 | 21 | 42 | 47 | 37 |
| False Positives | 152 | 63 | 153 | 386 | 141 |
| True Negatives | 234 | 323 | 233 | 0 | 245 |
| False Negatives | 7 | 26 | 5 | 0 | 10 |
| Accuracy% | 63.3 | 79.4 | 63.7 | 10.9 | 61.4 |
| Sensitivity% | 85.1 | 44.7 | 89.4 | 100.0 | 91.5 |
| Specificity% | 60.6 | 83.7 | 60.6 | 0.0 | 57.8 |
| PPV% 2 | 20.8 | 25.0 | 21.3 | 10.9 | 20.8 |
| NPV% 3 | 97.1 | 92.6 | 97.9 | DBZ 4 | 96.1 |
| AUC 3 | 0.785 | 0.682 | 0.789 | 0.743 | 0.760 |
1 AUC—Area under the curve. 2 PPV—Positive Predictive Value. 3 NPV—Negative Predictive Value. 4 DBZ—Division by zero (error).
Figure 1Estimated economic results ($/animal) of five classification models compared with a person (control) classifying expected BRD morbidity risk of incoming cattle cohorts in the first 45 DOF across varying proportions of high-risk cohorts to low-risk cohorts (0–100%). Gray line represents the control ($0/animal). At any prevalence, if the difference from the control for a model is above the control line ($0/animal) then it has a potential economic advantage relative to the control. If the difference from the control for a model is below the control line ($0/animal) then it has a potential economic disadvantage relative to the control.
Figure 2Flowchart of data refinement, data partitioning, algorithm training, and classification model algorithm evaluation.
Description of predictor and outcome variables.
| Variable | Description |
|---|---|
| Cohort size at arrival | Total animals in cohort upon arrival to the feedlot |
| Average arrival weight at arrival | Total weight of all animals/cohort size at arrival |
| Arrival Date Quarter 1,2 | Quarter of the year that cohort arrived (1,2,3,4) |
| Sex 1 | Gender of the cohort (steer, heifer, mixed gender) |
| Total pen area (sq. m) | Total area of the pen that cohorts were placed in |
| Bunk space length (m) | Total length of bunk available in pen |
| Pen area available per head (sq. m) | Total pen area/cohort size at arrival |
| Bunk space available per head (m) | Bunk space length/cohort size at arrival |
| BRD morbidity risk 3 | 1 = total cohort BRD morbidity risk ≥ 15% |
1 Qualitative variables that were converted to quantitative variables as dummy variables. 2 1 (January, February, Mar), 2 (April, May, June), 3 (July, August, September), 4 (October, November, December). 3 Binary outcome variable.
Figure 3Flowchart of diagnostic outcomes and calculations generated from predictive classification models using cutoff of 15% BRD morbidity in the first 45 DOF.
Variables included in the economic analysis to compare the cost benefit of using one of the predictive models compared with the control scenarios.
| Variable | Value |
|---|---|
| Total number of lots 1 | 1733 |
| Average cohort size 2 | 109 |
| Cost of single metaphylactic treatment per animal 3 | $23.60 |
| Prevalence of high-risk cohorts (%) | 0–100 |
| Cost of morbid animal 4 | $151.18 |
| BRD morbidity% in true positives 5 | 27% |
| BRD morbidity% in true negatives 6 | 3% |
| Metaphylaxis efficacy 7 | 0.5 |
1 Total of number of cohorts in study population. 2 Average cohort size in study population. 3 Average cost per animal to administer metaphylaxis (USDA 2013). 4 Average cost of a sick animal [33]. 5 Average morbidity in the true positive (high-risk) cohorts in study population. 6 Average morbidity in the true negative (low-risk) cohorts in study population. 7 Metaphylaxis efficacy set at 0.5 (50%) to represent reduced morbidity after metaphylaxis treatment [35].
Possible diagnostic outcomes associated with an economic analysis to evaluate the costs associated with correct or misclassification of cohort-level risk of bovine respiratory disease in first 45 days on feed.
| Diagnostic Outcome | Truth | Model | Metaphylaxis | Financial Consequence |
|---|---|---|---|---|
| TP | High risk | High risk | Treat | Animals that are truly high risk are metaphylactically treated. Treatment costs are incurred, but expenses are saved by avoiding lost value from potential morbid animals. |
| FN | High risk | Low risk | Do not treat | Animals that are truly high risk are not treated. These animals are expected to become morbid and provide lower value compared to healthy animals. The magnitude of financial loss was dependent on the prevalence of high-risk cohorts. |
| FP | Low risk | High risk | Treat | Animals that are truly low risk are metaphylactically treated. These animals are expected to be healthy, but received treatment regardless, so the incurred costs are only the treatment cost of metaphylaxis for animals in each cohort. |
| TN | Low risk | Low risk | Do not treat | Animals that are truly low risk are not metaphylactically treated. This is the baseline cost that was compared with all other outcomes. Since animals are expected to be healthy, and no treatment costs are incurred, the value for this outcome will always be $0. |